- Home
- GERN vs IRS Comparison
GERN vs IRS Comparison
Compare GERN & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- IRS
- Stock Information
- Founded
- GERN 1990
- IRS 1943
- Country
- GERN United States
- IRS Argentina
- Employees
- GERN N/A
- IRS N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- IRS Homebuilding
- Sector
- GERN Health Care
- IRS Real Estate
- Exchange
- GERN Nasdaq
- IRS Nasdaq
- Market Cap
- GERN 823.0M
- IRS 959.8M
- IPO Year
- GERN 1996
- IRS 1994
- Fundamental
- Price
- GERN $1.38
- IRS $11.34
- Analyst Decision
- GERN Buy
- IRS
- Analyst Count
- GERN 7
- IRS 0
- Target Price
- GERN $3.17
- IRS N/A
- AVG Volume (30 Days)
- GERN 6.7M
- IRS 298.3K
- Earning Date
- GERN 11-06-2025
- IRS 11-05-2025
- Dividend Yield
- GERN N/A
- IRS 8.83%
- EPS Growth
- GERN N/A
- IRS N/A
- EPS
- GERN N/A
- IRS 0.20
- Revenue
- GERN $164,447,000.00
- IRS $416,589,564.00
- Revenue This Year
- GERN $175.15
- IRS N/A
- Revenue Next Year
- GERN $56.61
- IRS N/A
- P/E Ratio
- GERN N/A
- IRS $5.72
- Revenue Growth
- GERN 11877.20
- IRS N/A
- 52 Week Low
- GERN $1.09
- IRS $10.61
- 52 Week High
- GERN $4.50
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- GERN 44.59
- IRS 34.09
- Support Level
- GERN $1.26
- IRS $11.25
- Resistance Level
- GERN $1.48
- IRS $11.91
- Average True Range (ATR)
- GERN 0.07
- IRS 0.58
- MACD
- GERN -0.00
- IRS -0.03
- Stochastic Oscillator
- GERN 13.64
- IRS 0.00
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.